Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 7684038, 9 pages
http://dx.doi.org/10.1155/2016/7684038
Research Article

Bioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic Nephropathy

1Centre for Public Health, Queen’s University Belfast, Belfast BT12 6BA, UK
2Conway Institute, University College Dublin, Dublin 4, Ireland

Received 28 November 2014; Revised 18 May 2015; Accepted 24 May 2015

Academic Editor: Georgia Fousteri

Copyright © 2016 Gareth J. McKay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Gilg, C. Castledine, and D. Fogarty, “Chapter 1 UK RRT incidence in 2010: national and centre-specific analyses,” Nephron Clinical Practice, vol. 120, supplement 1, pp. c1–c27, 2012. View at Google Scholar
  2. C. J. Hill, C. R. Cardwell, C. C. Patterson et al., “Chronic kidney disease and diabetes in the national health service: a cross-sectional survey of the U.K. national diabetes audit,” Diabetic Medicine, vol. 31, no. 4, pp. 448–454, 2014. View at Publisher · View at Google Scholar
  3. N. Sandholm, R. M. Salem, A. J. McKnight et al., “New susceptibility loci associated with kidney disease in type 1 diabetes,” PLoS Genetics, vol. 8, no. 9, Article ID e1002921, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Harjutsalo, S. Katoh, C. Sarti, N. Tajima, and J. Tuomilehto, “Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes,” Diabetes, vol. 53, no. 9, pp. 2449–2454, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. B. I. Freedman, C. D. Langefeld, L. Lu et al., “Differential effects of MYH9 and APOL1 risk variants on FRMD3 association with diabetic ESRD in African Americans,” PLoS Genetics, vol. 7, no. 6, Article ID e1002150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. W. He, C. Dai, Y. Li, G. Zeng, S. P. Monga, and Y. Liu, “Wnt/β-catenin signaling promotes renal interstitial fibrosis,” Journal of the American Society of Nephrology, vol. 20, no. 4, pp. 765–776, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-L. Lin, J.-Y. Wang, J.-Y. Ko, Y.-T. Huang, Y.-H. Kuo, and F.-S. Wang, “Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction,” Journal of the American Society of Nephrology, vol. 21, no. 1, pp. 124–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Ho, P.-H. Lee, Y.-C. Hsu, F.-S. Wang, Y.-T. Huang, and C.-L. Lin, “Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis,” American Journal of the Medical Sciences, vol. 344, no. 5, pp. 374–382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Faherty, H. O'Donovan, D. Kavanagh et al., “TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation,” BMC Genomics, vol. 14, article 525, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Steinberg, S. de Jong, O. A. Andreassen et al., “Common variants at VRK2 and TCF4 conferring risk of schizophrenia,” Human Molecular Genetics, vol. 20, no. 20, Article ID ddr325, pp. 4076–4081, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. T. Veeman, J. D. Axelrod, and R. T. Moon, “A second canon: functions and mechanisms of β-catenin-independent Wnt signaling,” Developmental Cell, vol. 5, no. 3, pp. 367–377, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Habas and I. B. Dawid, “Dishevelled and Wnt signaling: is the nucleus the final frontier?” Journal of Biology, vol. 4, no. 1, article 2, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Liu, “New insights into epithelial-mesenchymal transition in kidney fibrosis,” Journal of the American Society of Nephrology, vol. 21, no. 2, pp. 212–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Ivanova, M. J. Butt, and D. G. Matsell, “Mesenchymal transition in kidney collecting duct epithelial cells,” The American Journal of Physiology—Renal Physiology, vol. 294, no. 5, pp. F1238–F1248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. U. Ullmann, C. Gilles, M. De Rycke, H. Van de Velde, K. Sermon, and I. Liebaers, “GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions,” Molecular Human Reproduction, vol. 14, no. 3, pp. 169–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Levine and R. Tjian, “Transcription regulation and animal diversity,” Nature, vol. 424, no. 6945, pp. 147–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Orphanides, T. Lagrange, and D. Reinberg, “The general transcription factors of RNA polymerase II,” Genes and Development, vol. 10, no. 21, pp. 2657–2683, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. T. I. Lee and R. A. Young, “Transcription of eukaryotic protein-coding genes,” Annual Review of Genetics, vol. 34, pp. 77–137, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J. W. Conaway, L. Florens, S. Sato et al., “The mammalian mediator complex,” FEBS Letters, vol. 579, no. 4, pp. 904–908, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. G. A. Maston, S. K. Evans, and M. R. Green, “Transcriptional regulatory elements in the human genome,” Annual Review of Genomics and Human Genetics, vol. 7, pp. 29–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ptashne and A. Gann, “Transcriptional activation by recruitment,” Nature, vol. 386, no. 6625, pp. 569–577, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. D. H. Kavanagh, D. A. Savage, C. C. Patterson et al., “Association analysis of canonical Wnt signalling genes in diabetic nephropathy,” PLoS ONE, vol. 6, no. 8, Article ID e23904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. H. Kavanagh, D. A. Savage, C. C. Patterson et al., “Haplotype association analysis of genes within the WNT signalling pathways in diabetic nephropathy,” BMC Nephrology, vol. 14, no. 1, article 126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Elkon, C. Linhart, R. Sharan, R. Shamir, and Y. Shiloh, “Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells,” Genome Research, vol. 13, no. 5, pp. 773–780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. W. W. Wasserman and A. Sandelin, “Applied bioinformatics for the identification of regulatory elements,” Nature Reviews Genetics, vol. 5, no. 4, pp. 276–287, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. R. C. McLeay and T. L. Bailey, “Motif Enrichment Analysis: a unified framework and an evaluation on ChIP data,” BMC Bioinformatics, vol. 11, article 165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. Bryne, E. Valen, M.-H. E. Tang et al., “JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update,” Nucleic Acids Research, vol. 36, no. 1, pp. D102–D106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. I. H. de Boer, T. C. Rue, Y. N. Hall, P. J. Heagerty, N. S. Weiss, and J. Himmelfarb, “Temporal trends in the prevalence of diabetic kidney disease in the United States,” The Journal of the American Medical Association, vol. 305, no. 24, pp. 2532–2539, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. G. Pezzolesi, G. D. Poznik, J. C. Mychaleckyj et al., “Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes,” Diabetes, vol. 58, no. 6, pp. 1403–1410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Bonomo, M. Guan, M. C. Ng et al., “The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease,” Human Molecular Genetics, vol. 23, no. 24, pp. 6441–6447, 2014. View at Publisher · View at Google Scholar
  31. M. Kanehisa, S. Goto, M. Furumichi, M. Tanabe, and M. Hirakawa, “KEGG for representation and analysis of molecular networks involving diseases and drugs,” Nucleic Acids Research, vol. 38, no. 1, pp. D355–D360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Schmid, A. Boucherot, Y. Yasuda et al., “Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy,” Diabetes, vol. 55, no. 11, pp. 2993–3003, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. K. I. Woroniecka, A. S. D. Park, D. Mohtat, D. B. Thomas, J. M. Pullman, and K. Susztak, “Transcriptome analysis of human diabetic kidney disease,” Diabetes, vol. 60, no. 9, pp. 2354–2369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. C. E. Hills, G. B. Willars, and N. J. Brunskill, “Proinsulin C-peptide antagonizes the profibrotic effects of TGF-β1 via up-regulation of retinoic acid and HGF-related signaling pathways,” Molecular Endocrinology, vol. 24, no. 4, pp. 822–831, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. J. Ryan, G. Johnson, J. Kirk, S. M. Fuerstenberg, R. A. Zager, and B. Torok-Storb, “HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney,” Kidney International, vol. 45, no. 1, pp. 48–57, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Eckert, S. Buhl, S. Weber, R. Jäger, and H. Schorle, “The AP-2 family of transcription factors,” Genome Biology, vol. 6, no. 13, article 246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Orso, D. Corà, B. Ubezio, P. Provero, M. Caselle, and D. Taverna, “Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes,” BMC Genomics, vol. 11, no. 1, article 355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Pellikainen, V. Kataja, K. Ropponen et al., “Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer,” Clinical Cancer Research, vol. 8, no. 11, pp. 3487–3495, 2002. View at Google Scholar · View at Scopus
  39. W. Wang, L. Lv, K. Pan et al., “Reduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosis,” PLoS ONE, vol. 6, no. 9, Article ID e24897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Biadasiewicz, S. Sonderegger, P. Haslinger et al., “Transcription factor AP-2α promotes EGF-dependent invasion of human trophoblast,” Endocrinology, vol. 152, no. 4, pp. 1458–1469, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. Q. Li and R. H. Dashwood, “Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells,” The Journal of Biological Chemistry, vol. 279, no. 44, pp. 45669–45675, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. J. F. Morris, R. Hromas, and F. J. Rauscher III, “Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core,” Molecular and Cellular Biology, vol. 14, no. 3, pp. 1786–1795, 1994. View at Google Scholar · View at Scopus
  43. L. Bavisotto, K. Kaushansky, N. Lin, and R. Hromas, “Antisense oligonucleotides from the stage-specific myeloid zinc finger gene MZF-1 inhibit granulopoiesis in vitro,” Journal of Experimental Medicine, vol. 174, no. 5, pp. 1097–1101, 1991. View at Publisher · View at Google Scholar · View at Scopus
  44. Y.-H. Hsieh, T.-T. Wu, J.-H. Tsai, C.-Y. Huang, Y.-S. Hsieh, and J.-Y. Liu, “PKCα expression regulated by Elk-1 and MZF-1 in human HCC cells,” Biochemical and Biophysical Research Communications, vol. 339, no. 1, pp. 217–225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Y. Tan and L. M. Khachigian, “Sp1 phosphorylation and its regulation of gene transcription,” Molecular and Cellular Biology, vol. 29, no. 10, pp. 2483–2488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. K. Ghosh, Y. Mori, E. Dowling, and J. Varga, “Trichostatin A blocks TGF-β-induced collagen gene expression in skin fibroblasts: involvement of Sp1,” Biochemical and Biophysical Research Communications, vol. 354, no. 2, pp. 420–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Baugé, O. Cauvard, S. Leclercq, P. Galéra, and K. Boumédiene, “Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta,” Arthritis Research and Therapy, vol. 13, no. 1, article R23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Zhang, J. Ma, K. Brismar, S. Efendic, and H. F. Gu, “A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study,” Journal of Diabetes and its Complications, vol. 23, no. 4, pp. 265–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. S. L.-A. Samson and N. C. W. Wong, “Role of Sp1 in insulin regulation of gene expression,” Journal of Molecular Endocrinology, vol. 29, no. 3, pp. 265–279, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Yang and R. A. Weinberg, “Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis,” Developmental Cell, vol. 14, no. 6, pp. 818–829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. A. P. Sanchez and K. Sharma, “Transcription factors in the pathogenesis of diabetic nephropathy,” Expert Reviews in Molecular Medicine, vol. 11, article e13, 2009. View at Publisher · View at Google Scholar · View at Scopus